On-demand app for IBD patients in remission
Part of Digestive system clinical trials.
This trial tests an app that lets you check in with your IBD care team only when you need to, instead of having regular appointments. It's for people with Crohn's disease or ulcerative colitis who are doing well and have been on the same medication for at least 3 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with Crohn's disease or ulcerative colitis.
- You have not changed your IBD medications in the last 3 months.
- Your disease is currently quiet (remission) based on stool tests and symptom scores.
- You do not have a stoma, ileo-anal pouch, or ileorectal anastomosis.
- You speak Dutch well enough to use a smartphone app and have a smartphone or tablet with internet.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether remote monitoring, using an app and home stool tests, can be a safe alternative to frequent clinic visits for people with stable IBD. If you qualify, you'll have fewer in-person appointments and more flexibility.
This study aims to improve care and reduce health gaps for people with inflammatory bowel disease using text-message surveys to track symptoms and guide better disease management.
This trial tests a self-management program for people with active Crohn's disease or ulcerative colitis. It aims to improve quality of life by helping you better manage your condition.
This study tests a device called AIRE-2 that analyzes your breath to see if it can help manage IBD symptoms. It is for people with IBD who are in remission but still have IBS-like symptoms like belly pain or bloating.
This study tests whether digital tools, like a smartphone app and a wearable activity tracker, can help monitor your inflammatory bowel disease (IBD). You would use these tools and answer questionnaires to help doctors better understand your condition.
This study is testing a new way to check inflammation in people with active IBD using non-invasive devices (like a smartwatch or sensor). It aims to find a simpler method than blood tests or stool samples, which could help manage your condition more easily.
Hear when a new Telemonitoring trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.